Aveanna Healthcare (NASDAQ:AVAH) Director Rodney Windley Sells 180,000 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Director Rodney Windley sold 180,000 shares of the stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $2,070,000.00. Following the completion of the sale, the director directly owned 2,078,017 shares of the company’s stock, valued at approximately $23,897,195.50. This trade represents a 7.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Aveanna Healthcare Stock Performance

NASDAQ:AVAH opened at $13.70 on Tuesday. The firm’s 50-day moving average is $9.71 and its 200-day moving average is $7.95. Aveanna Healthcare Holdings Inc. has a 52-week low of $5.93 and a 52-week high of $13.98. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. The company has a market cap of $2.99 billion, a price-to-earnings ratio of 11.14, a PEG ratio of 0.92 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, August 13th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The business had revenue of $670.48 million during the quarter, compared to analyst estimates of $638.61 million. Equities research analysts anticipate that Aveanna Healthcare Holdings Inc. will post 0.68 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on AVAH. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 15th. Royal Bank Of Canada upped their target price on Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a research note on Monday. BMO Capital Markets raised their target price on Aveanna Healthcare from $10.00 to $14.00 and gave the stock an “outperform” rating in a research report on Friday, August 14th. Raymond James Financial lifted their price target on shares of Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research note on Friday, August 14th. Finally, UBS Group boosted their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a report on Friday, August 14th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of “Moderate Buy” and an average price target of $12.89.

Institutional Trading of Aveanna Healthcare

Large investors have recently bought and sold shares of the stock. AQR Capital Management LLC boosted its stake in shares of Aveanna Healthcare by 21.2% in the 1st quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after purchasing an additional 4,602 shares in the last quarter. Goldman Sachs Group Inc. increased its position in shares of Aveanna Healthcare by 8.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 339,853 shares of the company’s stock worth $1,842,000 after purchasing an additional 25,974 shares in the last quarter. Jane Street Group LLC lifted its holdings in Aveanna Healthcare by 522.0% during the 1st quarter. Jane Street Group LLC now owns 75,081 shares of the company’s stock valued at $407,000 after purchasing an additional 63,010 shares during the last quarter. Creative Planning lifted its holdings in Aveanna Healthcare by 15.1% during the 2nd quarter. Creative Planning now owns 47,025 shares of the company’s stock valued at $246,000 after purchasing an additional 6,171 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its position in Aveanna Healthcare by 65.0% in the second quarter. JPMorgan Chase & Co. now owns 158,265 shares of the company’s stock valued at $828,000 after buying an additional 62,348 shares in the last quarter. 87.96% of the stock is currently owned by institutional investors.

Trending Headlines about Aveanna Healthcare

Here are the key news stories impacting Aveanna Healthcare this week:

• Positive Sentiment: Royal Bank of Canada raised its price target from $10 to $16 and upgraded its rating to “outperform,” implying additional upside from the stock’s recent trading level. Benzinga analyst coverage
• Positive Sentiment: Truist Financial lifted its price target from $11 to $15 while maintaining a “hold” rating. The higher target reflects improved valuation expectations, even though Truist remains cautious on the shares. Benzinga analyst coverage
• Negative Sentiment: Insiders and major shareholders disclosed approximately 48.6 million shares of sales at an average price of $11.50, worth roughly $558.5 million. Sellers included Paul R. Vigano, Robert M. Williams Jr., and J.H. Whitney Equity Partners V, as well as CEO Jeff Shaner, director Rodney D. Windley, and insider Edwin C. Reisz. Although the sellers retained sizable positions, the volume of stock coming to market may pressure AVAH and raise questions about shareholder confidence. SEC insider transaction filing

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.